Learn how Q-Pulse, a quality management solution, can help organisations within the life science industry to maintain data integrity. This is particularly critical for pharmaceutical companies.
The third webcast in this series focuses on ways to meet your health system’s specific needs and achieve a 360-degree view of your patients, processes, physicians, and costs without purchasing multiple, disparate solutions, and creating information silos.
Our speakers discuss their collective experience in working with organizations to create tailored platforms that provide convenient access to data collected by, and stored in, disparate clinical information systems and enabling that data to be securely used by users throughout the broader healthcare community. Actionable data – available to all users when they need it – serves as a foundation for analysis and decision-making aimed at improving how care is delivered.
You can find it online at http://www.informationbuilders.com/webevents/online/24637#sthash.RnwoH27x.dpuf
Analytics is a key enabler for life sciences and healthcare organizations to create better outcomes for patients, customers and other stakeholders across the entire healthcare ecosystem. While almost two-thirds of organizations across the healthcare ecosystem have analytics strategies in place, our research shows that only a fifth are driving analytics adoption across the enterprise. The key barriers are a lack of data management capabilities and skilled analysts, as well as poor organizational change management. To develop and translate insights into actions that enhance outcomes, organizations will need to collaborate across an expanding ecosystem.
Cloud computing promises to fundamentally transform the global healthcare industry. But most healthcare providers have only just started to understand the power of cloud to not only drive efficiency, but also to redefine collaboration, partnering, and business models. The IBM Institute for Business Value point-of-view explores the opportunities and implications of cloud computing to help global healthcare companies meet new competitive pressures and ever-expanding consumer expectations.
Learn how Q-Pulse, a quality management solution, can help organisations within the life science industry to maintain data integrity. This is particularly critical for pharmaceutical companies.
The third webcast in this series focuses on ways to meet your health system’s specific needs and achieve a 360-degree view of your patients, processes, physicians, and costs without purchasing multiple, disparate solutions, and creating information silos.
Our speakers discuss their collective experience in working with organizations to create tailored platforms that provide convenient access to data collected by, and stored in, disparate clinical information systems and enabling that data to be securely used by users throughout the broader healthcare community. Actionable data – available to all users when they need it – serves as a foundation for analysis and decision-making aimed at improving how care is delivered.
You can find it online at http://www.informationbuilders.com/webevents/online/24637#sthash.RnwoH27x.dpuf
Analytics is a key enabler for life sciences and healthcare organizations to create better outcomes for patients, customers and other stakeholders across the entire healthcare ecosystem. While almost two-thirds of organizations across the healthcare ecosystem have analytics strategies in place, our research shows that only a fifth are driving analytics adoption across the enterprise. The key barriers are a lack of data management capabilities and skilled analysts, as well as poor organizational change management. To develop and translate insights into actions that enhance outcomes, organizations will need to collaborate across an expanding ecosystem.
Cloud computing promises to fundamentally transform the global healthcare industry. But most healthcare providers have only just started to understand the power of cloud to not only drive efficiency, but also to redefine collaboration, partnering, and business models. The IBM Institute for Business Value point-of-view explores the opportunities and implications of cloud computing to help global healthcare companies meet new competitive pressures and ever-expanding consumer expectations.
The growth of the sustainability agenda and the role of facilities managementFM EXPO
This presentation on the growth of the sustainability agenda and the role of facilities management was presented by Neil Everitt at FM EXPO - The only dedicated communities management exhibition in the Middle East.
Visit www.fm-expo.com for more details
Infographic for the Infor EMEA System i User Survey 2013.
Infor’s EMEA System i Survey was carried out during March and April 2013 with over a thousand manager or higher decision-makers invited to participate and over a hundred responses collected.
South Florida Behavioral Health Network implemented a solution that has helped to reduce the probability of re-arrests of mental health patients by 50%
Your cognitive future: How next-gen computing changes the way we live and workIBM in Healthcare
The healthcare industry is undergoing significant change driven by six disruptive forces - rapid digitization, changing consumer expectations, regulatory complexities, increasing healthcare demand, shortage of skilled resources and elevating healthcare costs. To meet the implication of these forces, healthcare organizations must excel in engaging with consumers, discovering new ideas and taking effective decisions
Currently, traditional analytics capabilities are unable to exploit maximum value from the ever increasing data resource constraining organization’s achievements and performance. But cognitive computing has the ability to bridge this gap and can open up fresh opportunities for the healthcare industry. It is already helping healthcare organizations to provide personalized care, effective decisions and more innovative solutions.
St. Luke's Health System President and CEO Dr. David Pate's presentation to at the state of Idaho's Medicaid Managed Care Public Forum held in Boise on Dec. 13, 2011.
Cloud computing promises to fundamentally transform the global life sciences industry. But most life sciences organizations have only just started to understand the power of cloud to not only drive efficiency, but also to redefine collaboration, partnering, and business models.
Life sciences organizations are hungry for the capabilities that cloud can deliver, to meet new competitive pressures and ever-expanding consumer expectations.
This new IBM Institute for Business Value (IBV) Cloud point-of-view (POV) for the life sciences industry explores the opportunities and implications of cloud computing for global life sciences companies. It provides a roadmap to formulate and execute cloud strategies.
HealthXL is the global clearing house for innovation in healthcare. We catalyse collaboration between leading brands in healthcare and the most exciting tech companies to improve the lives of millions of people.
Our partners are Bupa, Cleveland Clinic, Becton Dickinson, IBM, ICON, ResMed, Janssen Healthcare Innovation, Linde Healthcare, Novartis, Partners HealthCare, Silicon Valley Bank and EY.
Together with our partners we establish audacious goals (Moonshots) to work towards within healthcare. Then we search for innovators in digital health that can work with us and our partners to achieve those Moonshots. We help them find each other, create business partnerships and facilitate their relationship through collaboration
Healthcare providers are ready and planning to assume increased levels of risk through commercial payer and Medicare contracting models and Medicare Advantage, according to a new Navigant analysis based on a survey conducted by HFMA.
More than 60% of providers struggle to derive optimal value from their EHRs and 85% believe consumer self-pay will continue to impact their organizations, according to an annual HFMA/Navigant survey of 108 provider CFOs and revenue cycle executives.
The growth of the sustainability agenda and the role of facilities managementFM EXPO
This presentation on the growth of the sustainability agenda and the role of facilities management was presented by Neil Everitt at FM EXPO - The only dedicated communities management exhibition in the Middle East.
Visit www.fm-expo.com for more details
Infographic for the Infor EMEA System i User Survey 2013.
Infor’s EMEA System i Survey was carried out during March and April 2013 with over a thousand manager or higher decision-makers invited to participate and over a hundred responses collected.
South Florida Behavioral Health Network implemented a solution that has helped to reduce the probability of re-arrests of mental health patients by 50%
Your cognitive future: How next-gen computing changes the way we live and workIBM in Healthcare
The healthcare industry is undergoing significant change driven by six disruptive forces - rapid digitization, changing consumer expectations, regulatory complexities, increasing healthcare demand, shortage of skilled resources and elevating healthcare costs. To meet the implication of these forces, healthcare organizations must excel in engaging with consumers, discovering new ideas and taking effective decisions
Currently, traditional analytics capabilities are unable to exploit maximum value from the ever increasing data resource constraining organization’s achievements and performance. But cognitive computing has the ability to bridge this gap and can open up fresh opportunities for the healthcare industry. It is already helping healthcare organizations to provide personalized care, effective decisions and more innovative solutions.
St. Luke's Health System President and CEO Dr. David Pate's presentation to at the state of Idaho's Medicaid Managed Care Public Forum held in Boise on Dec. 13, 2011.
Cloud computing promises to fundamentally transform the global life sciences industry. But most life sciences organizations have only just started to understand the power of cloud to not only drive efficiency, but also to redefine collaboration, partnering, and business models.
Life sciences organizations are hungry for the capabilities that cloud can deliver, to meet new competitive pressures and ever-expanding consumer expectations.
This new IBM Institute for Business Value (IBV) Cloud point-of-view (POV) for the life sciences industry explores the opportunities and implications of cloud computing for global life sciences companies. It provides a roadmap to formulate and execute cloud strategies.
HealthXL is the global clearing house for innovation in healthcare. We catalyse collaboration between leading brands in healthcare and the most exciting tech companies to improve the lives of millions of people.
Our partners are Bupa, Cleveland Clinic, Becton Dickinson, IBM, ICON, ResMed, Janssen Healthcare Innovation, Linde Healthcare, Novartis, Partners HealthCare, Silicon Valley Bank and EY.
Together with our partners we establish audacious goals (Moonshots) to work towards within healthcare. Then we search for innovators in digital health that can work with us and our partners to achieve those Moonshots. We help them find each other, create business partnerships and facilitate their relationship through collaboration
Healthcare providers are ready and planning to assume increased levels of risk through commercial payer and Medicare contracting models and Medicare Advantage, according to a new Navigant analysis based on a survey conducted by HFMA.
More than 60% of providers struggle to derive optimal value from their EHRs and 85% believe consumer self-pay will continue to impact their organizations, according to an annual HFMA/Navigant survey of 108 provider CFOs and revenue cycle executives.
Role of Analytics in Delivering Health Information to help fight Cancer in Au...Deanna Kosaraju
Voices 2014
Role of Analytics in Delivering Health Information to help fight Cancer in Australia
Katerina Andronis,
Deloitte Consulting, Australia and Chandana Unnithan,
Deakin University, Australia
Technology is constantly transforming healthcare for the better, but getting technology right is an understated challenge for the industry. This webinar addresses three of healthcare's top challenges in tapping technology's full potential: cost, privacy and adoption. Experts and providers share tips, strategies and stories to help overcome these challenges to truly harness the power of transformative healthcare technology.
Big data governance as a corporate governance imperativeGuy Pearce
Poor data governance impacts reputation risk by data breach, by privacy violations and by acting on poor quality data. Furthermore, there are some important differences in what data governance means for big data compared to data governance for operational data.
That poor data governance impacts reputation risk means it has considerable implications for the Board of Directors, for whom reputation risk is the number one risk according to Deloitte (2013).
This presentation targeting the Board of Directors and the C-Suite and presented at the National Data Governance and Privacy Congress in Calgary, Canada presented some reasons why data governance is critical, from the perspective of both the C-Suite and the Board of Directors.
(Also on YouTube at http://youtu.be/QR4KO3Yx0n4)
The Role of Chief Medical Information OfficerReza Sadeghian
Reza Sadeghian, the dynamic Chief Medical Information Officer (CMIO) at ARMC, has revolutionized healthcare through his expertise in clinical informatics and Health Information Technology (HIT). His strategic leadership and IT restructuring have led to increased productivity and reduced costs, propelling ARMC into the forefront of data-driven patient care and innovation
As businesses generate and manage vast amounts of data, companies have more opportunities to gather data, incorporate insights into business strategy and continuously expand access to data across the organisation. Doing so effectively—leveraging data for strategic objectives—is often easier said
than done, however. This report, Transforming data into action: the business outlook for data governance, explores the business contributions of data governance at organisations globally and across industries, the challenges faced in creating useful data governance policies and the opportunities to improve such programmes.
Managing Privacy Risk and Promoting Ethical Culture in the Digital AgePerficient, Inc.
Businesses that responsibly manage privacy and educate their customers about their privacy practices benefit greatly - especially with regard to positive brand development.
MITS Advanced Research TechniquesResearch ProposalStudent’s NaEvonCanales257
MITS Advanced Research Techniques
Research Proposal
Student’s Name
Higher Education Department
Victorian Institute of Technology
Proposed Title: Data Integrity Threats to Organizations
Abstract
Data integrity, an integral aspect of cyber security, is identified as the consistence and accuracy that is assured of data in its life cycle, and is an imperative aspect of implementation, design, and utilization of systems which processes, stores, and retrieves data (Graham, 2017). It is estimated that almost 90 percent of the world’s data was generated in the last two year, and this goes to show the rate at which data is being availed. There are various threats associated with data integrity, for example, security, human, and transfer errors, cyber-attacks and malware just to name a few. The purpose of examination of data integrity in the context of organizations and business is due to the impact that it has on the latter’s operations and eventual success.
Data integrity is important when it comes to the productivity and operations of an organization, because management make decisions based on real-time data that is offered to them. If the data presented to management is inaccurate due to lack of proper data integrity, then the decisions that they make might have an adverse effect on an organization. For example, if data related to last year’s projections and profits in the finance department is altered in any way, then the decision of making plans in relation to an organization’s financial position might be lead to further losses. Organizations ought to prioritize security measures through there various Information Systems departments or by seeking third party cyber security specialties to protect and mitigate against the threats related to data integrity.
Outline of the Proposed Research
What are the threats associated with data integrity and the impact they have on organizational productivity and operations?
Background
Data plays an integral role in today’s business environment especially when most organizations are harnessing the benefits of data to facilitate their decision-making processes. It is through understanding why and how data is important in business that one may also comprehend the importance of ensuring the integrity of this same data is upheld. Most individual think that data security and integrity are one and the same thing, which is not true, as security refers to leaking of information such as intellectual property and healthcare documents, whereas data integrity refers to the process of ensuring whether data is trustworthy to facilitate the decision-making process.
Due to the lack of proper systems and structures to ensure that data integrity is at the helm of an organization’s priorities, management has found it difficult to solely rely on data and analytics to facilitate their decision-making process. What this means is that a significant number of businesses are missing out on the advantages accorded through aspects such ...
It’s been three years since the General Data Protection Regulation shook up how organizations manage data security and privacy, ushering in a new focus on Data Governance. But what is the state of Data Governance today?
How has it evolved? What’s its role now? Building on prior research, erwin by Quest and ESG have partnered on a new study about what’s driving the practice of Data Governance, program maturity and current challenges. It also examines the connections to data operations and data protection, which is interesting given the fact that improving data security is now the No. 1 driver of Data Governance, according to this year’s survey respondents.
So please join us for this webinar to learn about the:
Other primary drivers for enterprise Data Governance programs
Most common bottlenecks to program maturity and sustainability
Advantages of aligning Data Governance with the other data disciplines
In a post-COVID world, data has the power to be even more transformative, and 84% of business and technology professionals say it represents the best opportunity to develop a competitive advantage during the next 12 to 24 months. Let’s make sure your organization has the intelligence it needs about both data and data systems to empower stakeholders in the front and back office to do what they need to do.
Chapter 1The Transforming World of Health Information ManagemeEstelaJeffery653
Chapter 1
The Transforming World of Health Information Management
The Case for an Enterprise
Solution
The St. Rita’s Case
Who appointed the EIM team?
CIO Joan Morton
Why was EIM the team appointed?
Sort out the root causes of data integrity issues at St. Rita’s
Determine the feasibility of developing an enterprise division to assure data integrity
The St. Rita’s Case
The initial members of the EIM team
Denise – HIM professional
Bob – Business analyst
Linda – Decision support analyst
Val – Project manager
Shirlee – Clinical analyst
Monte – Systems analyst
The St. Rita’s Case
The EIM team’s charge
Study St. Rita’s data problems
Recommend new ideas and improvements
Assess feasibility of an EIM division
Develop an action plan to implement improvements
Enterprise Information Management
Enterprise information management (EIM)
A set of functions used by organization to plan, organize, and coordinate people, processes, technology, and content for managing information as a corporate asset that ensures data quality, safety, and ease of use.
Data Governance
Data governance (DG)
A specific EIM function that supports coordination among all other EIM functions by establishing data standards, policies, procedures, and accountabilities that span the entire organization.
Definition of
health information
Definition of Health Information
Definition dependent upon the context
Information about health science and health-related issues published by an authoritative source
For example, journals, magazines, web sources
Secondary patient-related data
For example, aggregated data in registries
Primary patient-related data
For example, specific patient data used for healthcare delivery
Electronic Health Records:
Differing Definitions
EMR – Electronic medical record
Electronic record
Health-related information about an individual
Is created, gathered, managed, and consulted by authorized clinicians and staff within one healthcare organization
National Alliance for Health Information Technology
Electronic Health Records:
Differing Definitions
EHR – Electronic health record
Electronic record
Health-related information about an individual
Conforms to nationally recognized interoperability standards
Is created, gathered, managed, and consulted by authorized clinicians and staff across more than one healthcare organization
National Alliance for Health Information Technology
Electronic Health Records:
Differing Definitions
PHR – Personal health record
Electronic record
Health-related information about an individual
Conforms to nationally recognized interoperability standards
Is drawn from multiple sources
Managed, shared, and controlled by the individual
National Alliance for Health Information Technology
Complexity of data flow and retrieval
Clinic Appointment and Visit Example
Healthcare Data Flow Across Users
Healthcare Information Exchanges (HIEs)
Federal-state collaboration
Enable and expand secure electronic movement and use of ...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
5. The problem is bigger than we think What you experience yourself and what you hear about is just the tip of the iceberg. Multiply that across all the DHBs, across all care settings, across the globe.